The efficacy and tolerability of agomelatine in patients with depressive disorders

Trial Profile

The efficacy and tolerability of agomelatine in patients with depressive disorders

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Jan 2014

At a glance

  • Drugs Agomelatine (Primary)
  • Indications Depressive disorders
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 14 Jan 2014 New trial record
    • 06 Nov 2013 Results presented at the 16th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top